BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Carb-X
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240313T080000
DTEND;TZID=America/New_York:20240315T170000
DTSTAMP:20260403T155646
CREATED:20240223T223718Z
LAST-MODIFIED:20240223T223718Z
UID:8213-1710316800-1710522000@carb-x.org
SUMMARY:Antimicrobial Resistance - Genomes\, Big Data and Emerging Technologies
DESCRIPTION:Antimicrobial resistance (AMR) is a major challenge in our globalised world\, and tackling it will take the combined resources and effort of researchers working across different disciplines. Technical advances in recent years continue to expand our ability to collect vast amounts of genomic information on pathogens\, and a wealth of data is being collected in epidemiological and surveillance studies\, including on the socio-economic burden of AMR. \nOur 4th conference in this series will bring together basic researchers\, clinicians\, computer scientists\, and policymakers interested in pathogen genomics\, epidemiology\, surveillance\, and machine learning to explore the recent advances and current challenges of the field. \nThis year’s programme will once again focus on genomic evidence and how to implement it in clinical practice and policy for AMR control. The meeting will highlight the advances in machine learning\, AI and computational tools to predict AMR. We will also discuss how to build an international genomics infrastructure to tackle AMR and emerging lessons from other global public health issues. \nThis conference will be a hybrid meeting – with onsite or virtual attendance. In addition to invited talks\, the programme will include short oral presentations selected from abstracts\, posters\, poster pitches and networking breaks for further discussion.
URL:https://carb-x.org/event/antimicrobial-resistance-genomes-big-data-and-emerging-technologies/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240315T143000
DTEND;TZID=Europe/Brussels:20240315T160000
DTSTAMP:20260403T155646
CREATED:20240222T165809Z
LAST-MODIFIED:20240222T165809Z
UID:8211-1710513000-1710518400@carb-x.org
SUMMARY:COMBINE Webinar | Development of Target Product Profiles for Antibiotics
DESCRIPTION:Calling all #healthcare innovators! 📢 Don’t miss out on the IMI COMBINE project webinar discussing Target Product Profiles for #antibiotic development. Join industry leaders from CARB-X\, Evotec\, and GSK on March 15\, 14:30 – 16:00 CET. \nDr. Erin Duffy\, Chief of R&D of CARB-X\, will be a panelist. \nTo register: https://limesurvey.biocom.de/index.php/191531?lang=en&newtest=Y \nFor more details on the webinar: https://amr-accelerator.eu/event/combine-webinar-on-developing-target-product-profiles-for-antibiotics/
URL:https://carb-x.org/event/combine-webinar-development-of-target-product-profiles-for-antibiotics/
END:VEVENT
END:VCALENDAR